Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AMINOCAPROIC ACID

02 3APREMILAST

03 4BRIVARACETAM

04 3BUPROPION HYDROCHLORIDE

05 1COLCHICINE

06 2DARUNAVIR

07 6DEFERASIROX

08 1DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

09 1DICLOFENAC POTASSIUM

10 2DICYCLOMINE HYDROCHLORIDE

11 2DIVALPROEX SODIUM

12 3DROXIDOPA

13 2ELETRIPTAN HYDROBROMIDE

14 2ELTROMBOPAG OLAMINE

15 2EMPAGLIFLOZIN

16 2EMPAGLIFLOZIN;LINAGLIPTIN

17 1ENALAPRIL MALEATE

18 2EPLERENONE

19 5FAMOTIDINE

20 2FLUVOXAMINE MALEATE

21 3GABAPENTIN

22 1GLYCEROL PHENYLBUTYRATE

23 1GLYCOPYRROLATE

24 1IBUPROFEN

25 1INDOMETHACIN

26 1ITRACONAZOLE

27 2IVABRADINE HYDROCHLORIDE

28 1LAMIVUDINE

29 5LURASIDONE HYDROCHLORIDE

30 1MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

31 3MESALAMINE

32 1METFORMIN HYDROCHLORIDE

33 3MEXILETINE HYDROCHLORIDE

34 2NABUMETONE

35 1NIMODIPINE

36 1NITAZOXANIDE

37 1NITROFURANTOIN

38 3OXCARBAZEPINE

39 1PANTOPRAZOLE SODIUM

40 3PIOGLITAZONE HYDROCHLORIDE

41 1PITOLISANT

42 2POLYETHYLENE GLYCOL 3350

43 2PROMETHAZINE HYDROCHLORIDE

44 2PRUCALOPRIDE SUCCINATE

45 3SAPROPTERIN DIHYDROCHLORIDE

46 2SOLIFENACIN SUCCINATE

47 3SPIRONOLACTONE

48 2THEOPHYLLINE

49 2TOFACITINIB

50 3VENLAFAXINE HYDROCHLORIDE

51 1VIGABATRIN

52 2ZAFIRLUKAST

53 1ZILEUTON

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : AMINOCAPROIC ACID

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : AMINOCAPROIC ACID

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : SOLUTION;ORAL

Brand Name : AMINOCAPROIC ACID

Dosage Strength : 0.25GM/ML

Packaging :

Approval Date : 2022-11-04

Application Number : 216464

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : APREMILAST

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : APREMILAST

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET;ORAL

Brand Name : APREMILAST

Dosage Strength : 10MG

Packaging :

Approval Date : 2023-07-26

Application Number : 211878

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : APREMILAST

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : APREMILAST

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET;ORAL

Brand Name : APREMILAST

Dosage Strength : 20MG

Packaging :

Approval Date : 2023-07-26

Application Number : 211878

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : APREMILAST

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : APREMILAST

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET;ORAL

Brand Name : APREMILAST

Dosage Strength : 30MG

Packaging :

Approval Date : 2023-07-26

Application Number : 211878

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : BRIVARACETAM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BRIVARACETAM

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET; ORAL

Brand Name : BRIVARACETAM

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number : 214831

Regulatory Info :

Registration Country : USA

blank

06

Brand Name : BRIVARACETAM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BRIVARACETAM

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET; ORAL

Brand Name : BRIVARACETAM

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number : 214831

Regulatory Info :

Registration Country : USA

blank

07

Brand Name : BRIVARACETAM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BRIVARACETAM

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET; ORAL

Brand Name : BRIVARACETAM

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number : 214831

Regulatory Info :

Registration Country : USA

blank

08

Brand Name : BRIVARACETAM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BRIVARACETAM

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET; ORAL

Brand Name : BRIVARACETAM

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number : 214831

Regulatory Info :

Registration Country : USA

blank

09

Brand Name : BUPROPION HYDROCHLOR...

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 100MG

Packaging :

Approval Date : 2023-05-31

Application Number : 216800

Regulatory Info : RX

Registration Country : USA

blank

10

Brand Name : BUPROPION HYDROCHLOR...

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
Aus. Peptide Conference
Not Confirmed

Annora Pharma

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 150MG

Packaging :

Approval Date : 2023-05-31

Application Number : 216800

Regulatory Info : RX

Registration Country : USA

blank